Song, G., Yang, D., Wang, Y., de Graaf, C., Zhou, Q., Jiang, S., Liu, K., Cai, X., Dai, A., Lin, G., Liu, D., Wu, F., Wu, Y., Zhao, S., Ye, L., Han, G.W., Lau, J., Wu, B., Hanson, M.A., Liu, Z.J., Wang, M.W., Stevens, R.C
doi: 10.1159/000445293 153 Vicente-MuozSMorcilloIPuChades-CarrascoLPayVPellicerAPineda-LucenaA
Importantly, unlike some weight loss medications associated with cardiovascular risks, GLP-1 agonists exhibit neutral or even beneficial cardiovascular outcomes, providing reassurance regarding their long-term safety
Alcohol disrupts the hypothalamic-pituitary axis by suppressing growth hormone-releasing hormone (GHRH) and elevating somatostatin, which directly inhibits GH secretion